Your browser doesn't support javascript.
loading
Safety and Antitumor Activity of Apalutamide (ARN-509) in Metastatic Castration-Resistant Prostate Cancer with and without Prior Abiraterone Acetate and Prednisone.
Rathkopf, Dana E; Antonarakis, Emmanuel S; Shore, Neal D; Tutrone, Ronald F; Alumkal, Joshi J; Ryan, Charles J; Saleh, Mansoor; Hauke, Ralph J; Bandekar, Rajesh; Maneval, Edna Chow; de Boer, Carla J; Yu, Margaret K; Scher, Howard I.
Afiliação
  • Rathkopf DE; Sidney Kimmel Center for Prostate and Urologic Cancers, Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. Rathkopd@mskcc.org.
  • Antonarakis ES; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland.
  • Shore ND; Carolina Urologic Research Center, Myrtle Beach, South Carolina.
  • Tutrone RF; Chesapeake Urologic Research Associates, Baltimore, Maryland.
  • Alumkal JJ; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
  • Ryan CJ; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.
  • Saleh M; University of Alabama Comprehensive Cancer Center, Birmingham, Alabama.
  • Hauke RJ; Nebraska Cancer Specialists, Omaha, Nebraska.
  • Bandekar R; Janssen Research & Development, Philadelphia, Pennsylvania.
  • Maneval EC; Aragon Pharmaceuticals, San Diego, California.
  • de Boer CJ; Janssen Biologics, B.V., Leiden, the Netherlands.
  • Yu MK; Janssen Research & Development, Los Angeles, California.
  • Scher HI; Sidney Kimmel Center for Prostate and Urologic Cancers, Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York.
Clin Cancer Res ; 23(14): 3544-3551, 2017 Jul 15.
Article em En | MEDLINE | ID: mdl-28213364

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tioidantoínas / Protocolos de Quimioterapia Combinada Antineoplásica / Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tioidantoínas / Protocolos de Quimioterapia Combinada Antineoplásica / Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article